secwatch.observer — SEC 8-K summary
======================================

Issuer:     Claritev Corp (CTEV)
CIK:        0001793229
Form:       8-K
Filed at:   2024-11-05T23:59:59+00:00
Accession:  0001793229-24-000146
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MultiPlan posts Q3 net loss $391.5M on $361.6M goodwill impairment; revenue down 5.1%
--------------------------------------------------------------------------------

- Revenue $230.5M (-5.1% YoY); net loss $391.5M vs loss $24.1M in Q3 2023.
- Adjusted EBITDA $141.6M (down from $152.3M); Free Cash Flow $41.1M (down from $49.7M).
- Recorded $361.6M impairment charge for goodwill and indefinite-lived intangibles.
- Identified $6.4B potential medical cost savings in Q3, +10% YoY.
- Updated FY2024 guidance: revenues $930-940M (previous $935-955M), Adj. EBITDA $580-590M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1793229/000179322924000146/0001793229-24-000146-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1793229/000179322924000146/mpln-20241105.htm
  HTML page:      https://secwatch.observer/filing/0001793229-24-000146

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer